Bipolar disorder is a mood disorder characterized by alternating, or co-occurring, episodes of mania or hypomania and episodes of depression, with a significant impact on daily functioning, quality of life, and clinical risk.
It is a chronic and recurrent condition that can affect personal, family, social, and occupational life. One of the major clinical challenges is that many people initially seek help for depressive symptoms, which can delay the correct diagnosis for years.
Bipolar disorder encompasses different clinical presentations involving pathological changes in mood, energy, and activity. These changes do not correspond to normal emotional variations, but rather to episodes that cause severe distress, functional impairment, and, in some cases, psychotic symptoms.
The main subtypes are:
- Bipolar I disorder: characterized by the presence of at least one manic episode.
- Bipolar II disorder: includes hypomanic episodes and major depressive episodes, but no full mania.
- Cyclothymia: involves subclinical hypomanic and depressive symptoms over an extended period.
- Other bipolar and related disorders: include forms induced by substances, medications, or medical conditions.
The difference between mania, hypomania, and bipolar depression
Understanding these phases is key to identifying bipolar disorder:
- Mania: an episode lasting at least one week, with an abnormally elevated, expansive, or irritable mood, accompanied by increased energy, impulsivity, a reduced need for sleep, grandiosity, and sometimes psychosis. It usually causes severe impairment and may require hospitalization.
- Hypomania: involves similar symptoms, but they are less intense and do not cause such marked functional impairment. Even so, it may go unnoticed or be incorrectly interpreted as a period of high performance.
- Bipolar depression: includes intense sadness, apathy, loss of interest, sleep disturbances, fatigue, difficulty concentrating, and thoughts of death. In many people, depression is the predominant phase.
Prevalence and scope of the problem
Bipolar disorder affects millions of people worldwide. It is estimated that approximately 0.5% of the global population lives with this diagnosis, although the figure may vary depending on the criteria used and the study methodology.
There is also a significant treatment gap: many people are not diagnosed in time or do not receive appropriate treatment. This contributes to relapses, greater disability, and a poorer prognosis.
Causes and risk factors
The origin of bipolar disorder is multifactorial. There is no single cause, but rather a combination of genetic, biological, psychological, and environmental factors.
Genetic factors
Research shows that bipolar disorder has high heritability. Having a family history increases risk, although it does not by itself determine whether the disorder will develop.
Neurobiological factors
Alterations have been described in brain circuits involved in emotional regulation, reward, sleep, and circadian rhythms. These alterations may contribute to affective instability and relapse.
Environmental and psychosocial factors
- Severe life stress
- Early trauma or childhood adversity
- Sleep disturbances
- Substance use
- Disrupted routines
These factors do not always cause the disorder, but they can act as triggers or worsen its clinical course.
Clinical course and prognosis
Bipolar disorder usually follows a chronic, recurrent, and episodic course. Relapses are common, so it is not enough to treat only acute episodes: a maintenance and prevention plan is also essential.
Many people alternate between periods of stability and depressive, hypomanic, or manic episodes. In others, depressive episodes predominate, making differential diagnosis from unipolar depression more difficult.
Some factors are associated with a poorer prognosis:
- Early onset
- Rapid cycling
- Mixed symptoms
- Substance use
- Poor treatment adherence
Common comorbidities
Bipolar disorder rarely occurs in isolation. Other mental or physical health problems commonly coexist.
Psychiatric comorbidities
- Anxiety disorders
- ADHD
- Substance use disorders
- Personality disorders
Medical comorbidities
- Obesity
- Metabolic syndrome
- Diabetes
- Cardiovascular disease
- Thyroid or kidney disorders
These comorbidities increase the disease burden and require regular physical monitoring.
Functional, social, and occupational impact
Bipolar disorder can profoundly affect autonomy and daily functioning. Common consequences include:
- Occupational difficulties
- Problems in family and romantic relationships
- Social isolation
- Stigma and discrimination
- Reduced quality of life
Therefore, care must go beyond symptom reduction and also focus on functional recovery.
Suicide risk
One of the most important aspects of bipolar disorder is its relationship with suicidal behavior. Scientific evidence shows a high lifetime prevalence of suicide attempts, making risk assessment an ongoing clinical priority.
Risk increases especially in the following situations:
- Depressive phases
- Mixed states
- Substance use
- History of previous attempts
- High impulsivity
Every treatment plan should include risk assessment, a safety plan, and close follow-up when necessary.
Clinical assessment and diagnosis
Diagnosis of bipolar disorder is clinical and requires a detailed assessment of the person’s history. There is no single biological test that confirms the diagnosis.
The assessment should include:
- Longitudinal history of mood episodes
- History of mania or hypomania
- Family history
- Substance use or medication use
- Psychotic symptoms
- Suicide risk
- Functional impact
It is also advisable to rule out medical causes and obtain baseline laboratory tests to guide treatment safely.
Screening tools
Questionnaires can help detect possible cases, although they do not replace the clinical interview. The most commonly used include:
- MDQ (Mood Disorder Questionnaire)
- HCL-32 (Hypomania Checklist)
- BSDS (Bipolar Spectrum Diagnostic Scale)
These tools can help identify people with suspected bipolar disorder, but a positive result does not by itself confirm its presence.
Treatment of bipolar disorder
Treatment should be comprehensive, individualized, and ongoing. The most effective approach combines pharmacotherapy, psychotherapy, psychoeducation, and clinical follow-up.
Pharmacological treatment
Medication selection depends on the clinical phase, relapse pattern, tolerability, comorbidities, and each person’s characteristics.
Acute mania or hypomania
During this phase, priorities include safety, reducing agitation, and restoring sleep. In severe cases, hospitalization may be necessary.
Commonly used treatments include:
- Lithium
- Valproate
- Quetiapine
- Risperidone
- Olanzapine
- Aripiprazole
Bipolar depression
Bipolar depression requires specific strategies, since inappropriate use of antidepressants may trigger a switch to mania or rapid cycling.
Common therapeutic options include:
- Quetiapine
- Lurasidone
- Lamotrigine for certain profiles
- Electroconvulsive therapy in severe or treatment-resistant cases
Antidepressant monotherapy is generally not recommended for bipolar disorder, especially when mixed features or a history of switching are present.
Maintenance treatment
The goal of maintenance treatment is to prevent relapses, reduce hospitalizations, and improve functioning. Commonly used medications include:
- Lithium
- Lamotrigine
- Quetiapine
- Other mood stabilizers or antipsychotics based on the clinical profile
Psychotherapy and psychoeducation
Psychological intervention is an essential part of treatment. It does not replace pharmacotherapy in most cases, but it does improve adherence, reduce relapses, and promote self-care.
Interventions with the strongest support include:
- Psychoeducation
- Cognitive behavioral therapy
- Interpersonal and social rhythm therapy
- Structured family-focused intervention
These strategies help to:
- Recognize prodromal symptoms
- Improve adherence
- Regulate sleep and routines
- Reduce stress
- Improve family communication
Crisis management
During a bipolar crisis, the goal is to act quickly to reduce risks and stabilize the person.
Manic episode
Urgent care may be required in the presence of:
- Severe agitation
- Psychosis
- Risky behaviors
- Lack of insight
- Inability to care for oneself
Severe depression with suicide risk
Immediate assessment is required if any of the following are present:
- Suicidal ideation
- Suicide plan
- Previous attempts
- Psychosis
- Substance use
In these situations, a safety plan, close follow-up, and, when necessary, urgent referral are essential.
Follow-up and relapse prevention
Effective follow-up for bipolar disorder is not limited to checking for symptoms. It should include:
- Sleep monitoring
- Early detection of relapse signs
- Treatment adherence
- Reducing substance use
- Metabolic, renal, endocrine, and cardiovascular monitoring
Recognizing early changes such as decreased sleep, increased activity, irritability, or impulsivity may allow early intervention and prevent more severe episodes.
Special considerations
Pregnancy and reproductive health
Use of valproate requires particular caution because of its high teratogenic risk. For women of childbearing potential, it is essential to assess pregnancy, contraception, and safe treatment alternatives.
Adolescence
In young people, diagnosis may be more complex because of overlap with conditions such as ADHD, conduct disorders, or substance use. A specialized approach is therefore often necessary.
Older adults
In later life, medical comorbidities, drug interactions, and treatment tolerability should be monitored more closely.
Conclusion
Bipolar disorder is a serious, complex, and potentially disabling mental health condition, but it is also treatable when identified early and addressed comprehensively.
Accurate diagnosis requires actively exploring a history of mania or hypomania, especially in people who seek help for depression. From there, treatment should combine pharmacological stabilization, psychotherapy, psychoeducation, physical monitoring, and relapse prevention.
Beyond controlling episodes, the true goal should be functional recovery, reduced suicide risk, and improved quality of life.
